Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell–Replete Haploidentical Donor Transplantation Using Post-Transplant CyclophosphamideAsad Bashey, Mary Eapen, Mei-Jie Zhang et al.|Journal of Clinical Oncology|2017Cited by 325
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United StatesLori Muffly, William A. Wood, Minoo Battiwalla et al.|Blood|2017Cited by 296
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysisScott Goldsmith, Marcie Riches, Muhammad Bilal Abid et al.|Blood|2021Cited by 177
The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantationStefan O. Ciurea, Arnon Nagler, Monzr M. Al Malki et al.|Bone Marrow Transplantation|2019Cited by 161
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remissionArmin Rashidi, Richard F. Olsson, Mehdi Hamadani et al.|Blood Advances|2019Cited by 128